{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:43:04Z","timestamp":1773279784980,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T00:00:00Z","timestamp":1471996800000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council of Australia","doi-asserted-by":"publisher","award":["1041835"],"award-info":[{"award-number":["1041835"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Victorian Government Operational Infrastructure Support Program"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.placenta.2015.07.001","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T01:23:57Z","timestamp":1436318637000},"page":"990-995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Serum HtrA1 is differentially regulated between early-onset and late-onset preeclampsia"],"prefix":"10.1016","volume":"36","author":[{"given":"Sonia Soo Yee","family":"Teoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiying","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.placenta.2015.07.001_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin. Perinatol."},{"issue":"Suppl.\u00a0A","key":"10.1016\/j.placenta.2015.07.001_bib2","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.placenta.2007.10.008","article-title":"Prediction of preeclampsia \u2013 a workshop report","volume":"29","author":"Than","year":"2008","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2015.07.001_bib3","first-page":"481095","article-title":"Public health perspectives of preeclampsia in developing countries: implication for health system strengthening","volume":"2011","author":"Osungbade","year":"2011","journal-title":"J.\u00a0Pregnancy"},{"issue":"7491","key":"10.1016\/j.placenta.2015.07.001_bib4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/bmj.330.7491.576","article-title":"The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community","volume":"330","author":"Milne","year":"2005","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.placenta.2015.07.001_bib5","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1161\/HYPERTENSIONAHA.113.02664","article-title":"Strategy for standardization of preeclampsia research study design","volume":"63","author":"Myatt","year":"2014","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.placenta.2015.07.001_bib6","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/HYPERTENSIONAHA.111.00250","article-title":"Redefining preeclampsia using placenta-derived biomarkers","volume":"61","author":"Staff","year":"2013","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.placenta.2015.07.001_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1081\/PRG-120021060","article-title":"Subclassification of preeclampsia","volume":"22","author":"von Dadelszen","year":"2003","journal-title":"Hypertens. Pregnancy"},{"issue":"3","key":"10.1016\/j.placenta.2015.07.001_bib8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-3016.2012.01260.x","article-title":"Secular trends in the epidemiology of pre-eclampsia throughout 40 years in Norway: prevalence, risk factors and perinatal survival","volume":"26","author":"Klungsoyr","year":"2012","journal-title":"Paediatr. Perinat. Epidemiol."},{"issue":"5","key":"10.1016\/j.placenta.2015.07.001_bib9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1053\/j.semperi.2011.05.010","article-title":"Management of late preterm and early-term pregnancies complicated by mild gestational hypertension\/pre-eclampsia","volume":"35","author":"Sibai","year":"2011","journal-title":"Semin. Perinatol."},{"issue":"6966","key":"10.1016\/j.placenta.2015.07.001_bib10","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/bmj.309.6966.1395","article-title":"Eclampsia in the United Kingdom","volume":"309","author":"Douglas","year":"1994","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.placenta.2015.07.001_bib11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0002-9378(93)90043-I","article-title":"Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)","volume":"169","author":"Sibai","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.placenta.2015.07.001_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nrm3065","article-title":"HTRA proteases: regulated proteolysis in protein quality control","volume":"12","author":"Clausen","year":"2011","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.placenta.2015.07.001_bib13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1097-2765(02)00658-5","article-title":"The HtrA family of proteases: implications for protein composition and cell fate","volume":"10","author":"Clausen","year":"2002","journal-title":"Mol. Cell."},{"issue":"4","key":"10.1016\/j.placenta.2015.07.001_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/156800909788486704","article-title":"HtrA serine proteases as potential therapeutic targets in cancer","volume":"9","author":"Chien","year":"2009","journal-title":"Curr. Cancer Drug Targ."},{"issue":"18","key":"10.1016\/j.placenta.2015.07.001_bib15","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1128\/MCB.00223-12","article-title":"High-temperature requirement protein A4 (HtrA4) suppresses the fusogenic activity of syncytin-1 and promotes trophoblast invasion","volume":"32","author":"Wang","year":"2012","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.placenta.2015.07.001_bib16","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.str.2012.03.021","article-title":"Structural and functional analysis of HtrA1 and its subdomains","volume":"20","author":"Eigenbrot","year":"2012","journal-title":"Structure"},{"issue":"2\u20133","key":"10.1016\/j.placenta.2015.07.001_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-5793(96)01229-X","article-title":"Primary structure of a putative serine protease specific for IGF-binding proteins","volume":"398","author":"Zumbrunn","year":"1996","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.placenta.2015.07.001_bib18","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1172\/JCI27698","article-title":"Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity","volume":"116","author":"Chien","year":"2006","journal-title":"J.\u00a0Clin. Invest"},{"issue":"8","key":"10.1016\/j.placenta.2015.07.001_bib19","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/sj.onc.1207271","article-title":"A\u00a0candidate tumor suppressor HtrA1 is downregulated in ovarian cancer","volume":"23","author":"Chien","year":"2004","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.placenta.2015.07.001_bib20","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1158\/0008-5472.CAN-09-3557","article-title":"Downregulation of HtrA1 promotes resistance to anoikis and peritoneal dissemination of ovarian cancer cells","volume":"70","author":"He","year":"2010","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.placenta.2015.07.001_bib21","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1074\/jbc.M500361200","article-title":"The role of human HtrA1 in arthritic disease","volume":"281","author":"Grau","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"issue":"3","key":"10.1016\/j.placenta.2015.07.001_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bone.2005.03.015","article-title":"Expression of mouse HtrA1 serine protease in normal bone and cartilage and its upregulation in joint cartilage damaged by experimental arthritis","volume":"37","author":"Tsuchiya","year":"2005","journal-title":"Bone"},{"issue":"17","key":"10.1016\/j.placenta.2015.07.001_bib23","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJMoa0801560","article-title":"Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease","volume":"360","author":"Hara","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"5801","key":"10.1016\/j.placenta.2015.07.001_bib24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.1133807","article-title":"HTRA1 promoter polymorphism in wet age-related macular degeneration","volume":"314","author":"Dewan","year":"2006","journal-title":"Science"},{"issue":"5801","key":"10.1016\/j.placenta.2015.07.001_bib25","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.1133811","article-title":"A\u00a0variant of the HTRA1 gene increases susceptibility to age-related macular degeneration","volume":"314","author":"Yang","year":"2006","journal-title":"Science"},{"issue":"Pt 1","key":"10.1016\/j.placenta.2015.07.001_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1042\/bj20021569","article-title":"Identification and cloning of two isoforms of human high-temperature requirement factor A3 (HtrA3), characterization of its genomic structure and comparison of its tissue distribution with HtrA1 and HtrA2","volume":"371","author":"Nie","year":"2003","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.placenta.2015.07.001_bib27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1369\/jhc.3A6186.2004","article-title":"The serine protease HtrA1 is upregulated in the human placenta during pregnancy","volume":"52","author":"De Luca","year":"2004","journal-title":"J.\u00a0Histochem. Cytochem."},{"issue":"5","key":"10.1016\/j.placenta.2015.07.001_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.04.046","article-title":"Elevated expression of serine protease HtrA1 in preeclampsia and its role in trophoblast cell migration and invasion","volume":"199","author":"Ajayi","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.placenta.2015.07.001_bib29","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.placenta.2012.08.003","article-title":"Upregulation of HtrA4 in the placentas of patients with severe pre-eclampsia","volume":"33","author":"Inagaki","year":"2012","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.placenta.2015.07.001_bib30","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/HJH.0b013e328344a82c","article-title":"Preeclampsia leads to dysregulation of various signaling pathways in placenta","volume":"29","author":"Kang","year":"2011","journal-title":"J.\u00a0Hypertens."},{"issue":"12","key":"10.1016\/j.placenta.2015.07.001_bib31","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.placenta.2012.09.011","article-title":"Alterations of maternal plasma HTRA1 level in preeclampsia complicated by IUGR","volume":"33","author":"Marzioni","year":"2012","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.placenta.2015.07.001_bib32","first-page":"690","article-title":"High temperature requirement A1 in placental tissues and serum from pre-eclamptic pregnancies with or without fetal growth restriction","volume":"9","author":"Zong","year":"2012","journal-title":"Arch. Med. Sci."},{"issue":"9","key":"10.1016\/j.placenta.2015.07.001_bib33","doi-asserted-by":"crossref","first-page":"e45956","DOI":"10.1371\/journal.pone.0045956","article-title":"HtrA3 as an early marker for preeclampsia: specific monoclonal antibodies and sensitive high-throughput assays for serum screening","volume":"7","author":"Dynon","year":"2012","journal-title":"PLoS One"},{"issue":"51","key":"10.1016\/j.placenta.2015.07.001_bib34","doi-asserted-by":"crossref","first-page":"34406","DOI":"10.1074\/jbc.273.51.34406","article-title":"Human HtrA, an evolutionarily conserved serine protease identified as a differentially expressed gene product in osteoarthritic cartilage","volume":"273","author":"Hu","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"issue":"4","key":"10.1016\/j.placenta.2015.07.001_bib35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/10641955.2012.667472","article-title":"Changes in the level of serum high-temperature requirement A1 (HtrA1) during pregnancy and its relationship to preeclampsia","volume":"31","author":"Zong","year":"2012","journal-title":"Hypertens. Pregnancy"},{"issue":"10","key":"10.1016\/j.placenta.2015.07.001_bib36","first-page":"1213","article-title":"Expression pattern alterations of the serine protease HtrA1 in normal human placental tissues and in gestational trophoblastic diseases","volume":"24","author":"Marzioni","year":"2009","journal-title":"Histol. Histopathol."},{"issue":"1","key":"10.1016\/j.placenta.2015.07.001_bib37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3346\/jkms.2007.22.1.94","article-title":"The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia","volume":"22","author":"Lee","year":"2007","journal-title":"J.\u00a0Korean Med. Sci."},{"issue":"10","key":"10.1016\/j.placenta.2015.07.001_bib38","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"5","key":"10.1016\/j.placenta.2015.07.001_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.08.010","article-title":"Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy","volume":"207","author":"McElrath","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.placenta.2015.07.001_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.06.030","article-title":"Angiogenic factors for the prediction of preeclampsia in high-risk women","volume":"197","author":"Moore Simas","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.placenta.2015.07.001_bib41","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.placenta.2015.07.001_bib42","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2174\/1381612811319060003","article-title":"HtrA protease family as therapeutic targets","volume":"19","author":"Skorko-Glonek","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.placenta.2015.07.001_bib43","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/path.4394","article-title":"Differential activation of placental unfolded protein response pathways implies heterogeneity in causation of early- and late-onset pre-eclampsia","volume":"234","author":"Yung","year":"2014","journal-title":"J.\u00a0Pathol."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400415300102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400415300102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:52:53Z","timestamp":1758909173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400415300102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0143400415300102"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2015.07.001","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum HtrA1 is differentially regulated between early-onset and late-onset preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2015.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}